Coronavirus
USA | Dec 12, 2020

US OKs Pfizer vaccine as American COVID deaths hurtle past World War II

/ Our Today

administrator
Reading Time: 3 minutes
The Food and Drug Administration (FDA) headquarters in White Oak, Maryland, United States.

(Reuters)

The United States (U.S.) said it authorised the use of Pfizer Inc’s COVID-19 vaccine on Friday, with the first inoculations expected within days, marking a turning point in a country that yesterday surpassed its 291,557 “battle deaths” For World War II. At 7:30 last night there were officially 294,690 deaths in the U.S. attributed to COVID-19.

The U.S. Food and Drug Administration granted an emergency use authorisation for the vaccine, developed with German partner BioNTech, which was shown to be 95 per cent effective in preventing the disease in a late-stage trial. It said the vaccine can be given to people aged 16 and older.

Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of a first round of 2.9 million doses this month.

The headquarters of German biotech firm BioNTech in Mainz, Germany.

BioNTech Chief Executive Ugur Sahin said the vaccine “will help to save lives across the United States and could accelerate a return to normality.”

U.S. health authorities, shipping services, hospitals and pharmacies have been readying a nationwide inoculation campaign. Pfizer said it would start shipping immediately and state public health systems have been planning to begin shots as early as Monday.

The government plans to accelerate vaccinations in the coming weeks and months, especially if a second vaccine from Moderna Inc is quickly approved. An advisory group to the U.S. Centers for Disease Control and Prevention will meet on Saturday to make crucial recommendations about whether some groups such as pregnant women and 16-year-olds should be immunised.

The authorisation comes as cases are surging in the U.S., with thousands of deaths per day, while hospital intensive care units across the country are nearing capacity, threatening to overwhelm healthcare systems.

“It is one step in a sequence of steps that will bring this pandemic to an end,” said Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security.

He added: “A lot of people will be infected, a lot will be hospitalised and a lot will die before the vaccine is able to have a meaningful impact on spread.”

George Dyer, 90, receives the first Pfizer/BioNTech COVID-19 vaccine, administered by General manager of Covid Recovery Becky Board, at Croydon’s University Hospital, on the first day of the largest immunisation programme in the British history, in London, Britain December 8, 2020. (File Photo: Dan Charity/Pool via REUTERS)

The Pfizer/BioNTech vaccine was first approved in Britain earlier this month, and UK residents began receiving the shots on Tuesday. Canada also authorised the vaccine and expects to start inoculations next week.

Mexico, Bahrain and Saudi Arabia have also approved the Pfizer vaccine.

U.S. President Donald Trump, in a video posted on Twitter, trumpeted the achievement and blamed China for the pandemic. Critics have said his focus on China was aimed at deflecting attention from his missteps in combating the pandemic.

“The United States is the first nation in the world to produce a verifiably safe and effective vaccine. Today’s achievement is a reminder of America’s unlimited potential,” Trump said.

Comments

What To Read Next